Showing results (1541-1550 of 1,712) with videos related to

Sort By:
Pageof 172
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Molecular Therapy Oncolytics|February 22, 2021
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4Vijay G Bhoj, Lucy Li, Kalpana Parvathaneni, et al.
Frontiers in Immunology|October 6, 2025
Impact of pregnant mothers' previous COVID-19 infection and vaccination on newborns' serological profilingAlaa Masry, Mohammad A A Bayoumi, Prem Chandra, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Medial temporal lobe Tau-Neurodegeneration mismatch from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with ADXueying Lyu, Nidhi S Mundada, Christopher A Brown, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2025
Carotid and regional arterial stiffness and dementia-related imaging biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA)Sheina Emrani, Jordan Tanley, Christopher L Schaich, et al.
Cell Reports|September 1, 2021
Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformationsChady Nasrallah, Giuseppe Cannone, Julie Briot, et al.
Journal of Primary Care & Community Health|October 19, 2021
Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care SettingsMohamed Ahmed Syed, Hamda Abdulla A/Qotba, Ahmed Sameer Al Nuaimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2023
Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuumXueying Lyu, Michael Tran Duong, Long Xie, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Pageof 172